ORAI1 and ischemic stroke: Since STIM1/Orai1-mediated SOCE in platelets is sufficient for thrombus formation without affecting hemostasis, it is a promising target for the treatment of thrombo-occlusive disorders including arterial thrombosis, myocardial infarction and ischemic stroke.